Dr. Sharjeel Panjwani, MD

Dr. Panjwani practices at Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health.

Dr. Panjwani's NPI, 1841619236, was assigned on April 14, 2014. Dr. Panjwani holds Massachusetts license 274952.

Dr. Panjwani's primary practice is Baystate Medical Center, at 759 Chestnut Street, Springfield, MA 01199 in Hampden County. The practice phone is (413) 794-0000.

Dr. Panjwani's primary practice is Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health. Dr. Panjwani is also affiliated with Baystate Noble Hospital. The medical group on file is Baystate Medical Practices. Dmand AI also links Dr. Panjwani to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Panjwani practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Panjwani's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Panjwani is licensed in Massachusetts.

CMS data shows 163 Medicare services from Dr. Panjwani across 5 procedure codes in 2024, for 153 Medicare patients. Medicare paid $19,336 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Dr. Panjwani in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Panjwani's median patient age at 71, with 56% women.

In 2024, Dr. Panjwani wrote 219 Medicare Part D claims for 55 patients. 88% of them were for generic drugs. CMS names the drug for 137 of them, across 6 drugs with 11 or more claims each, at $9,141 in total drug cost. In 2023, CMS named 106 claims across 5 drugs.

Dr. Panjwani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Panjwani as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Panjwani from 1 drug or device company in 2020. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $25.